Video Experimental Relacionado

Updated: Jan 24, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Análisis de Redes Regulatorias de Célula Única Identifica Candidatos a Fármacos Adyuvantes en Psoriasis Tratada

Yupeng Ma¹, Shumin Zhang², Xinhong Chen³

¹University of Shanghai for Science and Technology School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai 200093, China.

Current pharmaceutical design

|January 23, 2026

Resumen

Este estudio identificó factores de transcripción clave y predijo cinco fármacos de molécula pequeña, como alitretinoína y simvastatina, como alternativas o coadyuvantes potenciales al risankizumab para el tratamiento de la psoriasis.

Área de la Ciencia:

Inmunología
Dermatología
Biología Computacional

Sus antecedentes:

El risankizumab es eficaz para la psoriasis, pero tiene limitaciones como el costo y los posibles efectos secundarios.
La identificación de terapias alternativas o adyuvantes para la psoriasis es clínicamente importante.

Objetivo del estudio:

Caracterizar la regulación transcripcional de las células inmunitarias durante el tratamiento temprano con risankizumab para la psoriasis.
Identificar dianas terapéuticas potenciales y fármacos de molécula pequeña para la psoriasis.

Principales métodos:

Análisis de datos de secuenciación de ARN de célula única de células dendríticas y células T CD4+.
Se realizaron análisis de expresión diferencial, comunicación celular y redes de factores de transcripción.
Se utilizaron la predicción de fármacos de molécula pequeña y el acoplamiento molecular.

Principales resultados:

Quince factores de transcripción clave se alteraron significativamente en las células T CD4+ durante el tratamiento temprano con risankizumab.
Se identificaron genes diferencialmente expresados aguas abajo relacionados con la función de barrera cutánea.
Se predijeron cinco fármacos candidatos (alitretinoína, simvastatina, MS-275, colchicina, (+)-chelidonina).

Conclusiones:

El estudio caracterizó los cambios transcripcionales en la psoriasis durante el tratamiento con risankizumab.
Se identificaron dianas terapéuticas potenciales y fármacos de molécula pequeña.
Los hallazgos sugieren futuras estrategias de combinación para el manejo de la psoriasis.

Palabras clave:

Psoriasis Risankizumab Secuenciación de ARN de célula única predicción de fármacos regulación inmunitaria red de factores de transcripción

Más Videos Relacionados

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

Using SCOPE to Identify Potential Regulatory Motifs in Coregulated Genes

Using SCOPE to Identify Potential Regulatory Motifs in Coregulated Genes

Published on: May 31, 2011

Videos de Conceptos Relacionados

Cis-regulatory Sequences

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...

Cis-regulatory Sequences

Cis-regulatory Sequences

Protein Networks

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

Protein Networks

Protein Networks

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...

Network Covalent Solids

Network Covalent Solids

Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...